Addressing the Increasing Challenges of Cardiovascular-Kidney-Metabolic Syndrome for Health Systems 

The Problem  Cardiovascular-kidney-metabolic syndrome, also known as CKM syndrome, is a complex disorder attributed to a connection among obesity, diabetes, chronic kidney disease (CKD) and cardiovascular disease (CVD).1,2 CKM syndrome affects nearly every major organ in the body and includes two distinct but overlapping conditions: 1) cardiorenal syndrome and 2) cardiometabolic disorder.1   While both disorders… Continue reading Addressing the Increasing Challenges of Cardiovascular-Kidney-Metabolic Syndrome for Health Systems 

Customer Engagement Review: Brain and Behavioral Health

The Problem  The global burden of brain disorders, which include mental health conditions, neurological disorders and cerebrovascular diseases (e.g., depression, dementia and stroke), is staggering.1 It is estimated that there will be 4.9 billion cases of brain disorders by 2050, a >20% increase from 2021.1 These disorders present significant challenges for patients, families, healthcare systems… Continue reading Customer Engagement Review: Brain and Behavioral Health

Optimizing Health System Infrastructure for Clinical Trial Success 

Photo by Pavel Danilyuk on Pexels.com

From the technological systems that handle data collection to the physical facilities that safely deliver complex therapies to patients, appropriate health system infrastructure is critical to the successful conduct and completion of clinical trials. Nevertheless, health systems are often fragmented,1-2 under-resourced3 and lacking in well-established processes, equipment or physical facilities to deliver the coordinated care… Continue reading Optimizing Health System Infrastructure for Clinical Trial Success 

Identifying the Stakeholders Vital to Clinical Trial Success

Photo by Pavel Danilyuk on Pexels.com

Health systems are not static; they transform with new financial pressures, market trends, care delivery models, and technological advancements. At Petauri Kinect, we believe that pharmaceutical and biotechnology companies should align trial strategies with a deep understanding of health system stakeholder engagement, infrastructure, enrollment & referral patterns, and education.   There has never been a more… Continue reading Identifying the Stakeholders Vital to Clinical Trial Success

Understanding the Health System Dynamics Impacting Clinical Trials 

Photo by Artem Podrez on Pexels.com

Clinical trials are a foundational element of the US healthcare system. According to the National Library of Medicine, the number of registered clinical trial studies worldwide surged at a compound annual growth rate of approximately 27% from 2000 to 2023.1 The dramatic increase underscores a trial’s role in advancing health and science–from discovering new treatments… Continue reading Understanding the Health System Dynamics Impacting Clinical Trials 

BHN Member Co-Authors Article in NEJM Catalyst

Behavioral Health Leaders Network (BHN) member Dr. John Sawyer, PhD, ABPP-CN co-authored an article in NEJM Catalyst Innovations in Care Delivery. The paper, “Making the Business Case for Value-Based Dementia Care,” discusses tactics and emerging best practices to help transform dementia care for patients and their caregivers. To view the article, please visit here.  To learn… Continue reading BHN Member Co-Authors Article in NEJM Catalyst